首页> 外国专利> Pharmaceutical composition for preventing or treating listeriosis and candidiasis comprising Toxoplasma gondii-GRA7 recombinant protein as an active ingredient

Pharmaceutical composition for preventing or treating listeriosis and candidiasis comprising Toxoplasma gondii-GRA7 recombinant protein as an active ingredient

机译:以弓形体弓形虫-GRA7重组蛋白为有效成分的预防或治疗李斯特菌和念珠菌病的药物组合物

摘要

The present invention relates to a pharmaceutical composition for preventing or treating listeriosis and candidiasis, comprising a recombinant protein derived from a Toxoplasma gondii dense granule antigen 7 (GRA7) antigen. When the recombinant GRA7 protein derived from Toxoplasma gondii of the present invention is used as an antigen, an antibacterial reaction for infection by Listeria monocytogenes and Candida albicans can be remarkably improved, and thus the present invention can be useful to prevent or treat listeriosis and candidiasis.
机译:本发明涉及一种用于预防或治疗李斯特氏菌病和念珠菌病的药物组合物,其包含衍生自弓形虫致密颗粒抗原7(GRA7)抗原的重组蛋白。当将本发明的来自弓形体的弓形虫的重组GRA7蛋白用作抗原时,可显着改善单核细胞增生性李斯特菌和白色念珠菌感染的抗菌反应,因此本发明可用于预防或治疗李斯特菌和念珠菌病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号